Literature DB >> 25389000

Response to letter to the editor, "BET inhibitor JQ1 blocks inflammation and bone destruction".

S Meng1, Q Tu2, D Murray2, J Chen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25389000      PMCID： PMC7754802          DOI： 10.1177/0022034514557674

Source DB:  PubMed          Journal:  J Dent Res        ISSN： 0022-0345            Impact factor:   6.116


× No keyword cloud information.
  9 in total

1.  Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone.

Authors:  Chafik Ghayor; Rita M Correro; Katrin Lange; Lindsay S Karfeld-Sulzer; Klaus W Grätz; Franz E Weber
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

2.  BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.

Authors:  S Meng; L Zhang; Y Tang; Q Tu; L Zheng; L Yu; D Murray; J Cheng; S H Kim; X Zhou; J Chen
Journal:  J Dent Res       Date:  2014-05-05       Impact factor: 6.116

3.  The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.

Authors:  Jake Shortt; Andy K Hsu; Benjamin P Martin; Karen Doggett; Geoffrey M Matthews; Maria A Doyle; Jason Ellul; Tina E Jockel; Daniel M Andrews; Simon J Hogg; Andrea Reitsma; David Faulkner; P Leif Bergsagel; Marta Chesi; Joan K Heath; William A Denny; Philip E Thompson; Paul J Neeson; David S Ritchie; Grant A McArthur; Ricky W Johnstone
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

4.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

5.  N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration.

Authors:  Blanca San Miguel; Chafik Ghayor; Martin Ehrbar; Ronald E Jung; Roger A Zwahlen; Peter Hortschansky; Hugo G Schmoekel; Franz E Weber
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

6.  Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.

Authors:  Younis M Khan; Paul Kirkham; Peter J Barnes; Ian M Adcock
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

7.  Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.

Authors:  Sujatha Venkataraman; Irina Alimova; Ilango Balakrishnan; Peter Harris; Diane K Birks; Andrea Griesinger; Vladimir Amani; Brian Cristiano; Marc Remke; Michael D Taylor; Michael Handler; Nicholas K Foreman; Rajeev Vibhakar
Journal:  Oncotarget       Date:  2014-05-15

8.  An epigenomic approach to therapy for tamoxifen-resistant breast cancer.

Authors:  Qin Feng; Zheng Zhang; Martin J Shea; Chad J Creighton; Cristian Coarfa; Susan G Hilsenbeck; Rainer Lanz; Bin He; Lei Wang; Xiaoyong Fu; Agostina Nardone; Yongcheng Song; James Bradner; Nicholas Mitsiades; Constantine S Mitsiades; C Kent Osborne; Rachel Schiff; Bert W O'Malley
Journal:  Cell Res       Date:  2014-05-30       Impact factor: 25.617

9.  Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.

Authors:  Yujie Tang; Sharareh Gholamin; Simone Schubert; Minde I Willardson; Alex Lee; Pratiti Bandopadhayay; Guillame Bergthold; Sabran Masoud; Brian Nguyen; Nujsaubnusi Vue; Brianna Balansay; Furong Yu; Sekyung Oh; Pamelyn Woo; Spenser Chen; Anitha Ponnuswami; Michelle Monje; Scott X Atwood; Ramon J Whitson; Siddhartha Mitra; Samuel H Cheshier; Jun Qi; Rameen Beroukhim; Jean Y Tang; Rob Wechsler-Reya; Anthony E Oro; Brian A Link; James E Bradner; Yoon-Jae Cho
Journal:  Nat Med       Date:  2014-06-29       Impact factor: 53.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.